An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
NanoString to Webcast Presentation from the 19th Annual Morgan Stanley Global Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
NanoString Technologies (NASDAQ:NSTG) has announced that CEO Brad Gray will present at the 19th Annual Morgan Stanley Global Healthcare Conference on September 9, 2021, at 2:45 PM ET. The live presentation will be accessible via webcast on the company's investor website. A replay will be available one hour post-presentation, archived for 60 days. NanoString is a leader in life science tools, with products like the nCounter® Analysis System and GeoMx® Digital Spatial Profiler, used for advanced genomic profiling in research.
Positive
None.
Negative
None.
SEATTLE--(BUSINESS WIRE)--
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 19th Annual Morgan Stanley Global Healthcare Conference.
Brad Gray, president and chief executive officer, is scheduled to present on Thursday, September 9, 2021 at 2:45pm ET. Interested parties can access the live webcast with accompanying slides from the investor section of the company’s website at www.nanostring.com. The webcast replay will be available one hour after the conclusion of the live presentation and archived for 60 days.
About NanoString Technologies, Inc.
NanoString Technologies is a leading provider of life science tools for discovery and translational research. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 4,300 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx® Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.
NanoString, NanoString Technologies, the NanoString logo, GeoMx, and nCounter are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
